jasper therapeutics is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies.   jasper’s lead compound, jsp191, is in clinical development as a cond

Jasper Therapeutics, Inc. Common Stock

Sold all JSPR

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Swapnil Patel

Sold 50% of JSPR

Sold 20% of JSPR

Riley Wong

New position in JSPR

Charlie Andrys

Sold 33% of JSPR